Elanco Animal Health Inc (NYSE:ELAN)
| 20.61 Delayed Data As of Jun 24 |  +0.67 / +3.36%Today’s Change | 19.56 Today|||52-Week Range 37.49 | -27.38% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Operating Activities | Net Income / Starting Line | -210.8M | -47.9M | -310.7M | 86.5M | |
| Depreciation | 236.9M | 254.4M | 318.4M | 296.0M | ||
| Total Other Cash Flow | 72.4M | 124.7M | 126.0M | 194.7M | ||
| Funds From Operations | 22.3M | 325.3M | 120.3M | 516.5M | ||
| Funds From/For Other Operating Expenses | 15.7M | 169.4M | -53.5M | 29.2M | ||
| Net Cash Flow - Operating Activities | 6.6M | 155.9M | 173.8M | 487.3M | ||
| Investing | Capital Expenditures | -100.1M | -110.3M | -98.6M | -134.5M | |
| Fixed Asset Disposal | 20.3M | 7.4M | 37.6M | 9.4M | ||
| Net Assets From Acquisitions | -5.3B | -45.0M | -882.1M | 0.00 | ||
| Other Investing - Uses | -42.5M | -34.2M | -21.5M | -1.9M | ||
| Other Investing - Sources | 410.0M | 0.00 | 0.00 | 0.00 | ||
| Net Cash Flow Investing | -5.0B | -182.1M | -964.6M | -127.0M | ||
| Financing | Short Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Long Term Borrowings | 0.00 | 0.00 | 0.00 | 2.5B | ||
| Long Term Debt Reduction | 0.00 | 0.00 | 0.00 | -7.5M | ||
| Net Proceeds Stock Sale | 0.00 | 0.00 | 0.00 | 1.7B | ||
| Common Preferred Redeemed | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Dividends | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Cash Dividends Paid - Total | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Sources - Financing | 5.4B | -- | 848.3M | -- | ||
| Other Uses - Financing | 0.00 | 149.6M | 800.0K | 4.2B | ||
| Net Cash Flow - Financing | 5.4B | -149.6M | 847.5M | -35.2M | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -19.8M | -26.0M | 7.9M | 29.0M | |
| Net Change In Cash | 364.4M | -175.8M | 56.7M | 325.1M | ||
